删除或更新信息,请邮件至freekaoyan#163.com(#换成@)

Ferroptosis, radiotherapy, and combination therapeutic strategies

本站小编 Free考研考试/2022-01-02

Guang Lei1,2,
Chao Mao2,
Yuelong Yan2,
Li Zhuang2,
Boyi Gan2,3,,
1. Department of Radiation Oncology, Hunan Cancer Hospital and The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, 410013, China;
2. Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA;
3. The University of Texas MD Anderson UTHealth Graduate School of Biomedical Sciences, Houston, TX, USA
Funds: B.G. is supported by Radiation Oncology Strategic Initiatives (ROSI) from The University of Texas MD Anderson Cancer Center.

Received Date: 2021-02-18
Rev Recd Date:2021-03-29
Publish Date:2021-11-12




Abstract
Ferroptosis, an iron-dependent form of regulated cell death driven by peroxidative damages of polyunsaturated-fatty-acid-containing phospholipids in cellular membranes, has recently been revealed to play an important role in radiotherapy-induced cell death and tumor suppression, and to mediate the synergy between radiotherapy and immunotherapy. In this review, we summarize known as well as putative mechanisms underlying the crosstalk between radiotherapy and ferroptosis, discuss the interactions between ferroptosis and other forms of regulated cell death induced by radiotherapy, and explore combination therapeutic strategies targeting ferroptosis in radiotherapy and immunotherapy. This review will provide important frameworks for future investigations of ferroptosis in cancer therapy.
Keywords: ferroptosis,
lipid peroxidation,
GPX4,
SLC7A11,
radiotherapy,
immunotherapy,
radiosensitization,
combination therapy



PDF全文下载地址:

http://www.protein-cell.org/article/exportPdf?id=a5e1ef53-e620-413b-80f4-a5293bea306f&language=en
相关话题/Ferroptosis radiotherapy combination